Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
Clinical trial NCT01974765 · COMPLETED
Trial details
- NCT number
- NCT01974765
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-05
- Primary completion
- 2022-02-28
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.